In the end, IL-35+ Bregs hindered the infiltration of CD8+ T cells, reduced TNF and IFN-γ cytokines production by CD4+ T cells, and promoted the accumulation of Foxp3+Tregs within the tumor [38,39]. The gene discussed is CD8A; the disease is neoplasm.